TrialClinical trialPHN-02822026-10-29 19:00 CT
Tirzepatide and Organ-specific Biological Aging
Source · ClinicalTrials.gov: peptide AND aging
TLDR
A study listed on ClinicalTrials.gov is enrolling by invitation to evaluate blood-based measures of organ-specific biological age, particularly in the brain. Researchers aim to examine how these measures relate to established clinical health indicators and respond to treatment with tirzepatide.
01—Key points
- 01The study focuses on blood-based biological aging measures, with particular attention to the brain.
- 02Researchers will investigate relationships with established clinical indicators of health and responses to tirzepatide.
- 03The excerpt provides no study results.
Why it matters Editorial
The study examines whether organ-specific biological aging measures respond to tirzepatide, without yet reporting evidence of an effect.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
02—Related news
Study
PHN-0004
2026-10-27 11:00 CT
Trial
PHN-0298
2026-10-05 19:00 CT
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
ClinicalTrials.gov: peptide AND aging